Weight Gain: A Possible Side Effect of All AntiretroviralsLucia Taramasso, Manfredi Mura, Nicola Squillace et al.|Open Forum Infectious Diseases|2017Cited by 89
Muscle symptoms and creatine phosphokinase elevations in patients receiving raltegravir in clinical practice: Results from the SCOLTA project long-term surveillanceGiordano Madeddu, Paolo Bonfanti, Giuseppe Vittorio De Socio et al.|International Journal of Antimicrobial Agents|2014Cited by 30
<p>Lipid profile improvement in virologically suppressed HIV-1-infected patients switched to dolutegravir/abacavir/lamivudine: data from the SCOLTA project</p>Paola Bagella, Giordano Madeddu, Nicola Squillace et al.|Infection and Drug Resistance|2019Cited by 28
Durability, safety, and efficacy of rilpivirine in clinical practice: results from the SCOLTA ProjectPaola Bagella, Giordano Madeddu, Giuseppe Vittorio De Socio et al.|Infection and Drug Resistance|2018Cited by 23